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Abstract: Human breast milk (HBM) is unique in its composition as it is adapted to fulfil the
newborns’ nutritional requirement and helps in improving the health of newborns. Besides various
nutrients, the human milk also contains diverse group of microbiotas. The human milk microbiota
has a remarkable impact on the growth and development of a newborn. Additionally, the human
milk microbiota enhances the colonization of microbes in the gut of infants. Debates about the origin
of HBM microbial flora remain premature and contradictory in some cases. Recent data suggest that
the maternal gut microbiota has a major impact on microbial composition, areolar skin, and from
the infant’s oral cavity. The current review investigates the possible route of microbial transfer from
the maternal gut to mammary gland and suggests that it might occur through the entero-mammary
pathway. It involves precise selection of probiotic microorganisms from the gut, as the human
gut hosts trillions of microorganisms involved in gut homeostasis and other metabolic pathways.
Gastrointestinal lymphatic vessels, macrophages, and dendritic cells are shown to play a significant
role in the microbial transmission. Furthermore, the role of microbial factors in the development of
neonatal immunity and translocation of secretory IgA (SIgA) cells from the intestinal lumen to GALT
and finally to mammary glands via entero-mammary link are discussed.
Keywords: breast milk; microbiome; probiotics; lactic acid bacteria; entero-mammary pathway
1. Introduction
Human breast milk (HBM) is the gold standard in care for all infants and children.
There are various nutritional and non-nutritional bioactive components in human milk.
To ensure survivability and healthy development, their compositions are dynamic and
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gradually altered as the newborn grows [1,2]. Human milk also harbors a unique mi-
crobial population that naturally develops from the first breastfeed. Due to its dynamic
nature and high heterogeneity, the human milk microbiota is also a complex and variable
ecosystem [3]. For many years, human milk was considered sterile, and the presence of
microorganisms was considered as a contamination or due to infection such as mastitis. Nu-
merous approaches, both culture-dependent and culture-independent, have revealed the
existence of diverse bacterial communities. The bacterial communities include Bifidobacteria,
Staphylococci, Streptococci, and other lactic acid bacteria [4–6].
Reports differ regarding the source of human milk microbiota. Their existence in the
secreted milk is expected to onset during the third trimester of pregnancy and continue
throughout the lactation period [7]. Studies have demonstrated that human milk microbiota
continuously supply beneficial bacteria into the newborns’ gut environment, contributing to
the maturation of the digestive and immune functions of the growing infant [8]. Although
human milk microbiota is dominated by skin microflora, the population of the beneficial
microbiome in the human milk are similar to the composition of gut microbiota. Probiotic
bacterial genera including lactic acid bacteria and Bifidobacteria are expected to originate
from the maternal gut environment [8,9]. The relationship between the gut and mammary
glands was confirmed in animal models [6]. In humans, studies have focused primarily
on describing the composition, functions, and factors affecting milk microbiota rather
than understanding the origin of milk microbiota from the maternal gut [8,9]. To address
this question, this review explores the possible bio-routes involved in the translocation of
gut origin microbiota into the mammary glands. Macrophages can distinguish between
pathogenic and commensal microflora in the gut, and they translocate probiotic strains
from maternal gut into the mammary glands [10]. Despite their beneficial nature, the
presence of any microbial cells or their antigens in the human blood would be considered
as infections, and there must be a specific route for gut microbial translocation—more
likely, we termed it the ‘microbial bio-route’. In this context, the aim of this study was to
discuss the composition of human milk microbiome and potential microbial translocation
into the human milk. Furthermore, we also highlighted the factors affecting human milk
microbial compositions and their likely effects on human health.
2. General Features of Human Milk Microbiota
Breast milk harbors a unique microbial population that varies across countries, eth-
nicities, or even among communities [11]. In the 1970s, there has been a quick rise in the
number of HBM banks in the United States and other European countries for newborns in
intensive care units (ICUs). The use of preserved milk raised concerns about the sterility of
the milk and hygiene issues of the donors [12,13]. Various microbiological and biochemical
analysis were performed on the HBM to check its safety before its availability for the
newborns (0–2 months) and infants (0–1 year)/babies (0–4 years). These clinical tests
eventually rejected the long-standing dogma that considered HBM as a sterile fluid [11].
Currently, powerful cutting-edge technologies in molecular biology research have dramat-
ically outperformed the traditional techniques in the assessment of the HBM microbial
quality. Currently used molecular techniques such as pyrosequencing of the DNA have
been extensively used to identify the complex microbial population in the HBM. These
techniques have proven that the HBM holds a unique microbial niche with outstanding
benefits for the infants’ growth and development [14]. However, HBM microbiome studies
are not completed yet and are still inconclusive.
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As culture-dependent methods have confirmed the presence of several bacteria in
the HBM collected from healthy women, HBM sample collections were questioned [15].
Figure 1 shows the global distribution of microbial phyla at their different sites including
maternal gut, breast milk, and the infant’s oral cavity. The origin of HBM microbiota is still
a matter of debate. However, growing evidence suggests that maternal gastrointestinal
microbiota and maternal breast skin or the infants’ oral microbiota might contribute to the
microbial population in human milk [16,17].
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Figure 1. The microbiota composition of the maternal gut, an milk, and infa ts’ oral cavity: a description of relative
abundances of essential phyla in each microbiota composition. Concentric cake diagrams schematically represent inter-
individual variability.
3. Microbial Partners of Human Milk ‘Factory’
Every breastfed baby receives approximately 104–106 bacterial cells daily, consuming
almost 800 mL of HBM [5,13,18,19]. Most of these microbiotas exis naturally with n the
HBM, and their diversity is unique. Culture-dependent and -independent techniques
have both revealed the diversity of the microbial population present in the HBM [14,20].
Relatively, the HMB has a large variability at the intra-individual level, and it undergoes
continuous changes over the lactation period [20]. Figure 2 illustrates the most isolated
microbial species from the human milk samples.
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Figure 2. 16S rRNA gene-based phylogenetic tree of the human milk core microbiota. The tree was constructed based on
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genome sequence data have been available since 2015. The analysis involved 49 nucleotide sequences. All the evolutionary
analyses were performed by using MEGA (version 7.0). All positions comprising gaps and missing data were removed. The
final dataset observed 1266 positions.
3.1. Predominance of Skin Microflora
Fitzstevens et al. [14] reported that Staphylococcus and Streptococcus strains were com-
monly found in almost all culture-independent quantification studies of HMB. The mem-
bers of Staphylococcus and Streptococcus genera are dominant skin microflora including
Propionibacterium, which was also reported to inhabit the infa t gut ecosystem. Therefore,
their predominance in uman milk indicates that t ey may be derived from mat rnal skin
or from gut microbes [11]. A study revealed that the microbial load in the milk samples
of healthy mothers originates from maternal areolar skin. It was predicted that the skin
bacteria from the breast surfaces of the nipple or areola could gain access through the ducts
of the mammary glands during breastfeeding [23,24].
Still, the question arises here, why does breast milk contain an abundance of oppor-
tunistic pathogenic genera such as Staphylococcus and Streptococcus? Traditionally, greater
amount of Staphylococcus aureus and Staphylococcus epidermidis in the HBM samples, along
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with other genera including Streptococci and Corynebacterium, were considered as the main
agents causing mastitis [25]. Mastitis is a condition of inflammation in lactating mammary
glands caused by microbial dysbiosis in the human milk microbiome and leads to oppor-
tunistic pathogenic bacteria outgrowth and a decline in healthy and stable commensal
bacteria [26]. Opportunistic pathogenic bacteria are the normal microflora that outgrow
in numbers due to several conditions including the compromised host’s immunity [15].
Patel et al. [21] reported that individuals with subacute mastitis and acute mastitis had
higher abundance of Proteobacteria than Firmicutes.
In addition, there have been several studies that reported that commensal skin mi-
croflora including Staphylococcus and Streptococcus were also found to be predominant in
the breast milk samples collected from healthy mothers [5,20,27]. O’Sullivan et al. [28]
reported that skin originated coagulase-negative Staphylococci was able to produce bac-
teriocin, which inhibits the growth of pathogenic bacteria. In addition, HBM contains
various antimicrobial proteins and peptides such as lactoferrin, beta-defensins, and alpha-
defensin [1,29]. Antimicrobial proteins and peptides present in breast milk show broad
inhibitory activity against a variety of pathogens like Streptococcus epidermidis, S. aureus,
E. coli, and Streptococcus agalactiae [26].
Previously, Hunt et al. [30] described the survivability of these skin microflorae in
human milk. The relative abundance of Staphylococci, especially S. aureus and S. epidermidis
strains, was expected due to the influence of human milk oligosaccharides (HMO). The
HMO are well-known for promoting the growth of various commensal bacteria in HBM
including Bifidobacterium spp. [31,32]. However, these HMOs were also found to stimulate
the growth and proliferation of S. aureus and S. epidermidis strains. Another interesting
fact is that these two strains fail to metabolize HMOs available in breast milk [25]. Hence,
conjectures can be made that this (above stated reason) could be the main factor for the
abundance of skin microflora in the breast milk, especially Staphylococci and Streptococci.
After breaching into the mammary glands from the areolar skin, these skin microflorae
could be stimulated to multiply by breast milk components. However, the bacterial group
survived by utilizing simple sugars rather than competing with the commensal bacteria of
the breast milk for HMOs.
Microbiota present naturally in human skin and breast milk plays a crucial role in
the immune system’s control of a newly born baby. During the breastfeeding process, a
significant microbial transmission potential occurs across the areolar skin barriers into the
mammary glands [10]. Eventually, this transfer into the infants’ gastrointestinal tract will
build a neutral microbial ecosystem consisting of beneficial and commensal microorgan-
isms. The introduction of these skin commensals into the infants’ gut modulates the innate
immunity [15,30,33–36].
3.2. Human Milk Is a Probiotic Consortium
Martin and colleagues [37] performed one of the earliest isolations on probiotics from
HBM. The study successfully described 78 rod-shaped lactic acid bacterial isolates that
grew on MRS medium [37]. The presence of Lactobacillus and Bifidobacterium strains in
the human milk has also been confirmed by other studies [38–40]. Sinkiewicz and Ljung-
gren [38] described the occurrence of Lactobacillus reuteri strains in 220 breast milk samples
by the culture-dependent method. Ozgun and Vural [41] characterized 100 presump-
tive Lactobacillus isolates from colostrum samples by using the API 50 CHL system from
BioMeriéux. This study identified several Lactobacillus strains of Lactobacillus brevis, Lacto-
bacillus plantarum, Lactobacillus fermentum, Lactobacillus rhamnosus, and L. reuteri. However,
certain lactic acid bacterial isolates share common phenotypes [41]. Soto et al. [42] utilized
qualitative PCR analysis, which revealed the presence of Lactobacillus and Bifidobacterial
DNA in 160 samples. The most frequently detected Lactobacillus species were L. salivarius,
L. fermentum, and L. gasseri. The study also reported the presence of Bifidobacterium breve
as the most common Bifidobacterial species [42]. In addition, Biagi et al. [43] also found
that the majority of probiotic bacterial OTUs, especially assigned to the Bifidobacterial
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group, were shared between breast milk and stool samples of the same mother–infant pairs.
This gives credence to the idea that the mother’s milk acts as a source of pioneer probiotic
bacteria for the infant’s gut microbiota [33,43].
Currently, more Lactobacillus and Bifidobacterium strains have been isolated from hu-
man milk to be utilized as potential probiotics [44,45]. Rajoka et al. [46] identified three
Lactobacillus strains recently isolated from human milk that exhibited probiotic properties.
The study also reported anti-cancer properties in their cell-free culture supernatants. Dama-
ceno et al. [5] characterized three probiotic potential strains, namely L. gasseri; B. breve, and
L. salivarius from healthy human milk. These strains agglutinated with different pathogens
instead of producing bacitracin. Besides, L. fermentum originating from human milk has
been exploited extensively to treat mastitis problems [47]. Several orally administrated
probiotic bacteria were also previously isolated from human milk samples [48,49].
Compared to many bacterial groups in mothers’ milk, the presence of Lactobacil-
lus and Bifidobacterium spp. has much more beneficial impact on the neonatal immune
system [50,51]. In addition, the presence of probiotic strains including Lactobacillus and
Bifidobacteria has a protective role where these bacterial strains suppress respiratory and
diarrheal infections at the initial infantile age [52,53]. Björkstén et al. [54] reported that
infants that have a slower colonization or a lower number of probiotic enterococci and
Bifidobacteria may be more vulnerable to gastrointestinal or allergic problems. Other
study by Johansson et al. [55] demonstrated that early colonization with Lactobacillus were
shown to decrease the effect of allergy. Despite there being no clear protective effect on
allergy response reported, breast milk is composed of key players to combat allergy [56,57].
Another recent systematic study demonstrated that the fecal microbiota of infants with
colic found that Bifidobacteria and Lactobacilli were greatly decreased in infants with colic
compared to the control infants [58]. Furthermore, the colic phenotype was found to be
positively associated with various Proteobacteria groups, but negatively associated with
bacteria belonging to the Firmicutes phyla, which includes certain lactobacilli and canonical
groups that manufacture butyrate and lactate. Interestingly, some studies have found that
administering a Lactobacillus strain believed to be from human milk to infants with infantile
colic can be beneficial [58,59].
3.3. Presence of Other Microorganisms
Besides Proteobacteria and Firmicutes, another common genus found in most of the
breast milk samples is Bacteroides. This bacterial genus is generally found in human
colostrum. Thus, their presence in HBM might have a vital role in the early establishment
of newborn gut microbiota [60]. Bacteroides fragilis can interact with intestinal dendritic cells
to stimulate cytokine production. This leads to T-cell proliferation in the lamina propria and
promotes physiological expansion of mucosal immunity in neonates [60,61]. Another of the
most abundant genus detected in healthy breast milk is Acinetobacter [3,22,23]. However, its
presence varies greatly in different studies. Sakwinska et al. [56] reported that abundance
of Acinetobacter was related to poor aseptic technique during sampling. Patel et al. [21]
reported a lower number of Acinetobacter in the breast milk samples collected after sterile
cleaning and refusal of foremilk samples.
The presence of fungal strains, especially yeast species in the early development of the
infant’s gut, was confirmed in human milk [62]. Further information about the naturally
existing fungal species in HBM is still lacking. Most of the previous detection has focused on
breast candidiasis, the mammary infection by pathogenic Candida species [27,63]. Jiménez
et al. [27] confirmed the presence of fungal sequences in a metagenomics analysis on HBM
samples collected from mastitis-suffering mothers. Boix-Amorós et al. [64] reported the
viable presence of Malassezia, Candida, and Saccharomyces species in the HBM samples from
healthy mothers. This was the first evidence to support the natural existence of fungal
species in the HBM. In addition, several studies have also described the presence of fungal
strains in the milk samples of other mammals [15,40,65].
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3.4. Predicting the Core of Human Milk Microbiota
Human milk core microbiota have been estimated by culture-independent tech-
niques [21,27,30]. Hunt et al. reported that the core of human milk microbiota consisted
of nine bacterial genera. Based on the pyrosequencing technique, various reports have
indicated the presence of Streptococcus, Staphylococcus, Serratia, and Corynebacteria as the
most abundant genera in human milk, besides Pseudomonas, Ralstonia, Propionibacterium,
Sphingomonas, and Bradyrhizobiaceae [30]. In contrast, Jimenez et al. used metagenomics
analysis on the milk samples from healthy mothers. Early reports suggest a microbial
core composed of seven genera including Staphylococcus, Streptococcus, Bacteroides, Fae-
calibacterium, Ruminococcus, Lactobacillus, and Propionibacterium [15]. Recently, Williams
et al. reported a microbial core of 10 bacterial groups that were abundantly found at
each time point throughout six months of postpartum. Streptococcus, Staphylococcus, and
Propionibacterium were found in all samples, whereas Pseudomonas, Veillonella, Pilibacter,
Gemella, Bacteroides, Prevotella, and Corynebacterium were found in more than 90% of sam-
ples [66]. Meanwhile, Murphy et al. [20] reported a core microbiota consisting of 12 genera
including Pseudomonas, Staphylococcus, Streptococcus, Elizabethkingia, Variovorax, Bifidobac-
terium, Flavobacterium, Lactobacillus, Stenotrophomonas, Brevundimonas, Chryseobacterium, and
Enterobacter. This study characterized the bacterial population in breast milk and infant
stool collected over the first three months of life, among 10 mother–infant pairs [20].
Therefore, determination of core microbiota in human milk is not easy to standard-
ize due to multiple factors such as geographic locations, milk collection and storage, or
analytical methods. Despite these variabilities, the core human milk microbiota is mostly
dominated by four bacteria phyla, which are Firmicutes (such as Staphylococcus, Clostrid-
ium, Lactobacillus), Actinobacteria (such as Propionibacterium, Corynebacterium), Proteobacteria
(such as Pseudomonas, Ralstonia, Sphingomonas, Bradyrhizobiaccea), and Bacteroidetes (such
as Prevotella) [14,15,21,30,66]. Fitzstevens et al. suggest that this human milk microbial
core might vary, but the reported additional genera in several studies are not consistently
represented in all of the studies [14]. Furthermore, these milk microbial compositions are
dynamic where it changes from highly diverse as lactation progresses [20,36,60].
Recently, it was confirmed that the microbial core in the human milk is not randomly
distributed [60]. The microbial composition in the human milk might be due to specific
localization. The study performed the first microbial network analysis in the breast milk
samples using artificial neural networks (ANNs) to highlight the natural links among
variables. Microbial networking enables a new understanding of the interactions existing
within a bacterial ecosystem. Microbiome is dynamic and highly heterogeneous, where
the role of each member is not often well-defined [67]. As a result, the bacterial network
is proving to be a valuable method for deciphering microbial associations and assessing
the effect of different interactions with the host. The study will identify the main “hubs”,
which is represented by the utmost significant member in a bacterial population [60,67].
Drago et al. reported that a streptococci variant, Abiotrophia spp., is an important hub
in the microbial network found in colostrum and mature milk from Italian women [68].
This bacterial genus is a common oral cavity microorganism that can also be found in the
genitourinary tract and gastrointestinal tract [69]. Thus, the researchers hypothesized that
its existence in human milk could be attributed to direct entrance through the mammary
ducts while breastfeeding [30] or the entero-mammary pathway [52]. Similarly, the study
also found lactic acid bacteria being main hubs for microbial networking in the colostrum
from Italian mothers. Furthermore, this analysis showed that mature milk samples had a
higher abundance of anaerobic intestinal bacteria than the colostrum samples [68].
4. Microbial Transmission: Solving the Labyrinth Path
Diverse hypotheses have been proposed for the common microorganisms between
mother and infants. The suggested core microbiota in the human milk is similar to predom-
inant bacterial phyla found in the human body [60,68].
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4.1. From the Areolar Skin
Human body skin is a critical interface to protect internal cells from the excessive
loss of moisture and entry of microorganisms [70,71]. Colonization of skin microbiota
begins from the delivery process [72]. Then, immunotolerance against commensal mi-
croorganisms is established during childhood and allows for the sustainability of skin
microbiota composition. During adulthood, the skin microbiota develops a balance that is
unique to every individual [71,73]. Beyond this individual microbial stability, the human
skin microbiota also vary across different bodies due to multiple factors including gender,
climate, lifestyle, and maintenance habits [74,75]. The four major phyla that have been
found in healthy skin were Actinobacteria, Firmicutes, Proteobacteria, and Bacteroides. Among
them, Staphylococcus, Propionibacterium, and Corynebacterium were the three predominant
genera found in human skin [70,76]. Female skin microbiota have been reported as being
more diverse than male [73]. The gender differences impact the skin microbial communities
due to behavioral characteristics such as the influence of hygiene practices and the use of
cosmetics [76]. The greater bacterial diversity on female skin might also be due to the skin
pH where men generally have a more acidic skin [73].
Chan and colleagues have published the first report on the quantification of microbial
population on women’s nipple and areolar skin [77]. Researchers used the 16S rRNA
gene sequencing technique to classify the microbiota found on the nipple surface. Both
nipple skin samples from healthy and breast cancer patients showed the presence of
Proteobacteria, Firmicutes, and Bacteroides as the predominant genera [77]. However, the
study did not correlate identified areolar microorganisms with breast milk or with the
infants’ gut. Pannaraj et al. demonstrated the first evidence that linked bacterial community
in the HBM with areolar skin microbiota [23]. It was found that the newborn received the
highest contribution of bacteria from mother’s milk and areolar skin during the first month
of life and the composition of bacteria received decreased as the infant grew up [23]. The
Proteobacteria including Moraxellaceae, Enterobacteriaceae, and Pseudomonadaceae constituted
the dominant phylum in the HBM whereas Firmicutes, especially Staphylococcaceae and
Streptococcaceae dominated the areolar skin [23,28].
4.2. Cross-Contamination from Infants’ Oral Cavity
The work done by Pannaraj et al. reported the involvement of areolar skin microbiota
in the breast milk [23]. The study also found that about 60% of infant gut microbiota came
from other sources than breast milk and areolar skin. However, the study did not further
characterize the sources [23]. One of the possible causes could be translocation from the-
newborn oral environment. When an infant is born by the natural method or C-sections
it’s oral cavity is exposed to the surrounding microbiota [43]. Li et al. reported that oral
microbiota differs between infants delivered by natural and C-section [72]. The naturally
delivered infants contained an abundance of Lactobacillus, Prevotella and Gardnerella genera
than the C-section infants who were more likely to have skin microflora such as Staphylo-
coccus, Pseudomonas, Desulfovibrio, and Petrimonas [68]. Naturally born infants could have
placental or vaginal microflora as they might take up some of the amniotic fluid during
delivery. This was confirmed with the discovery of various microorganisms found in the
meconium (first stool of infants) [78]. Therefore, some of the bacteria from the infants’ oral
cavity could cross-contaminate and move into the mammary glands during suckling. Biagi
et al. found that infants’ oral microbiota were the least diverse as Streptococcaceae are the
most common with an average relative abundance of 69.8 percent. The study also reported
that the baby’s mouth microbiota had similar identity between dominant Streptococcus
detected in their mothers’ milk. This finding suggests that infants’ oral microbiota can
produce a seeding consequence on the mammary gland microbial community during
nursing [43]. However, this factor does not clarify the presence of some bacteria in the
pre-colostrum, which are secreted in some women before delivery [3,37,43].
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4.3. Entero-Mammary Pathway: The ‘Silk Route’ to Trade Microbiota from Maternal Gut to Infant
4.3.1. Link between Maternal Gut and Breast Milk
The human gastrointestinal environment contains the highest and most diverse micro-
bial population compared to other body parts. Starting from the oral cavity to the rectum,
the gastrointestinal tract includes more than 800 species of microflora [79,80]. The gut mi-
crobiota is generally dominated by Firmicutes and Bacteroidetes phyla where their presence
and abundance are crucial in regulating body metabolism and energy harvesting [81,82].
However, the gut microbial population often changes over time with age, besides additional
factors such as type of diet, ingestion of alive microorganisms, host genotype, and health
status [80,81]. The gestation cycle is a structural transition in the female body that includes
hormonal, immunological, and metabolic modifications to promote fetal development and
growth. During this period, endocrine secretions (especially progesterone and estrogens)
are higher and there is major alteration in the immune response [9,79,81]. In addition, there
are also noticeable changes in the maternal gut microbiota during pregnancy [7,83].
A healthy gestation period is described with increased bacterial loading and changed
gut microbial composition [9]. Koren et al. first reported the gradual change of gut
microbiota during early pregnancy [83]. The feces of 91 pregnant women in their first
to third trimesters were analyzed by amplifying the V1–V2 variable region of the 16S
rRNA gene. Microbial composition of first trimester women was similar to healthy non-
pregnant women. However, gut microbiota composition evolved dramatically during
pregnancy with amplified loads of Actinobacteria and Proteobacteria, but their individual
richness was reduced [83]. Similarly, Smid et al. also described that the abundance of
maternal gut microbiota was reduced, and their variety and consistency were increased
from early pregnancy (≤20 weeks) to the end of the third trimester [7]. The changes in
gut microbial population over time plays a critical role in normal pregnancy in promoting
weight gain, raising maternal metabolic adaptations, and supporting the growth of the
fetus [9,81,83]. Even after birth, the maternal microbiota does not appear to return to its
previous state [83]. As the postpartum period is linked to significant hormonal shifts, it was
expected that it could reveal more interesting facts of the hormonal effect on the maternal
gut microbiome [9].
Despite the microbial transition before or after postpartum periods, it is an immensely
popular fact that maternal gut has a great influence on the breast milk microbiota. Martin
et al. performed the earliest comparison on the origin of milk microbiota using random
amplification of the polymorphic DNA (RAPD) technique [37]. The RAPD profiles of lactic
acid bacteria isolates from breast milk were compared with other isolates collected from
various body sites. The study explained that none of the lactic acid bacteria isolates from
the breast milk were identical to those from the breast areolar skin surface [37,84]. This
is also supported by the research done by Soto et al. [42]. The study reported that the
presence of skin microflora in the HBM samples seems to be widespread. However, the pres-
ence of Lactobacillus and Bifidobacterium must originate from the maternal gastrointestinal
environment [42].
Albesharat et al. conducted a study for a large number of isolates by using RAPD
and matrix assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-
TOF-MS) analyses [85]. The researchers found that the RAPD genotypes of L. plantarum,
L. fermentum, L. brevis, Enterococcus faecium, Enterococcus faecalis, and P. pentosaceus recovered
from breast milk, mothers’ guts, and infants’ feces were identical [85]. Jost et al. utilized the
pyrosequencing technique to reveal vertical sharing of microbiota between maternal gut,
breast milk and infant’s gut [33]. Despite the predominance of skin microflora, the study
also found that gastrointestinal anaerobic bacteria including Bacteroides, Bifidobacterium,
Blautia, Clostridium, Collinsella, Parabacteroides, Veillonella, and facultative Lactobacillus spp.
were detected in all three ecosystems analyzed. Jost et al. reported that Bacteroides and
Bifidobacterium strains had the highest potential for vertical transfer from maternal gut into
her breast milk samples [33]. The above-mentioned studies assist the statement that the
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maternal gut bacteria reach the breast milk and colonize the gut of the breast-fed neonate
through entero-mammary pathway trafficking [17,86].
However, only certain gut species have been identified from breast milk. Sampling
and selective transfer of a specific strain or composition of maternal gut microbiota into the
mammary glands remain to be completely explored. Milani et al. performed metagenomics
investigation to highlight the transmission of probiotic Bifidobacterial communities as they
are important representatives in the intestinal microbiota of infants [86]. With Bifidobacte-
rial ITS profiling coupled with shotgun metagenomics analyses performed in the study, a
common Bifidobacterial profile was identified to be similar among the mother–infant pairs.
The targeted genome reconstruction from the microbiome also confirmed that these specific
Bifidobacterial strains were persistent in the infant gut for six months after birth [69,86].
Later, the same group revealed that Bifidobacterial communities are widely spread among
mammalian groups that include domesticated animals such as dogs, cats, cows, sheep,
goats, horses, and pigs as well as 46 other non-primate mammals including humans and
13 non-human primates [8]. The study reported that the Bifidobacterial strains were found
to be transferred from the mother through breast milk. These findings support the hypoth-
esis that probiotics bacteria found in HBM, especially Bifidobacterial strains, are directly
acquired from the maternal gut. However, they might be found at very low abundance,
and this could be to favor an ultimate transfer to the following generation [8,17,69,86].
4.3.2. Mucosal Sampling and Migration of Dendritic Cells
The pathway of transmitting maternal microbiota from the gut to breast milk (entero-
mammary pathway) can be linked to the improvement of the immunity in newborns [45,87].
The mother passes down some of her immunoglobulin (Ig) to the developing fetus to
acquire passive immunity during the pregnancy period. IgG is the only antibody that can
cross the placental barrier in humans through endosomes within the syncytiotrophoblasts
of the placenta [88,89]. After giving birth, the maternal immunity is still being successfully
transferred and passive immunity is achieved as the lactating mammary glands takes
over the functionality of the placenta [89]. Breast-feeding maintains a strong interaction
between the mother and her infant by continuing the transfer of maternal immunoglobulin
molecules into the newborn.
SIgA is the predominant class of Ig found in HBM and is released by the antibody-
secreting cells found in the mammary glands. However, the mammary gland does not
seem to stand alone because it is highly influenced by the antibodies produced by the
mother in her own gut [90]. During the late pregnancy and lactation stage, the maternal IgA
antibody-secreting cells, found in the gut and in the respiratory system, are translocated
into the mammary glands [91,92]. The gut mucosal epithelial chemokine CCL28 is the
key regulator of the build-up of IgA antibody-secreting cells. The build-up of these cells
occurs in the lactating mammary gland. A study using BALB/c mice as the animal model
revealed that blocking of CCL28 can lead to significant accumulation of IgA plasma cells
in lactating mammary glands [93]. Therefore, the data suggest an internal pathway to
transport these antibody-secreting plasma cells from the maternal gastrointestinal tract
to her mammary glands, without involving blood circulatory vessels. Furthermore, the
translocation is regulated by specific carrier cells [51].
It has been recognized for many years that human lymphatic vessels exhibit a high ca-
pacity for accumulating particulate material. The human lymphatic system not only drains
the lymph, but is also responsible for moving the immune cells of lymphocytes and anti-
bodies throughout the body to help initiate and participate in an immune response. Several
blind ended vessels and fine capillaries of the lymphatic system are found throughout the
human body [94,95]. Gut associated lymphoid tissue (GALT) is the main lymphatic present
around the gastrointestinal tract (Figure 3) comprising of Peyer’s patches, isolated follicles,
and mesenteric lymph nodes [94,96]. The GALT serves as antigen sampling and inductive
sites of the mucosal immune system. SIgA cells from the gut can adhere selectively to
specific M cells found in the intestinal Peyer’s patches. This will mediate the translocation
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of the SIgA cells from the intestinal lumen to GALT, and finally to mammary glands via
the entero-mammary link [97]. The migration of SIgA cells from the gastrointestinal tract
to mammary glands is believed to be under the regulation of hormones such as prolactin,
estrogen, and progesterone [98].
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Migration of antibody-secreting cells such as SIgA to HBM, originating from the mater-
nal gut, could clearly explain the existence of lymphatic systems and the entero-mammary
pathway [91]. However, the sampling and translocation of maternal gut microorganisms
into breast milk is b st explained by he dendritic c lls (DCs). These cells are found
throughout many sites including intestinal tissues. DCs actively migrate between the
intestinal lamina propria, GALT, Peyer’s patches, isolated lymphoid follicles, and in the
mesenteric lymph nodes [97,99]. The main function of DCs is to sample antigens found
in the intestinal lumen, then migrate into lymphatic nodes and present antigens into T
cells to induce their proliferation and differentiation [99]. Several studies have suggested
that DCs such as CD11c+ and CX3CR1+ macrophage cells can extend their trans-epithelial
dendrites through the tight junction in the intestinal epithelium to capture luminal antigens
or bacteria [33,99,100].
Farache et al. used 2-photon microscopy in live mice to evaluate the microbial sam-
ling by CD103+ DCs in the mesentery lymph nodes [101]. These DCs engulfed Salmonella
bacteria in the lamina propria and rapidly retracted toward the soma [101]. The study
reported that CD103+ DCs translocated Salmonella bacteria in two steps [102–104]. First,
some DCs were found to sense the presence of bacteria and started to secrete chemokines
to stimulate more DCs to migrate to the epithelium. Then, the newly arrived DCs extended
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their dendrites toward the lumen by penetrating the tight junction between intestinal cells.
The dendrites were extended in response toward the chemokines and started to engulf the
bacteria. The DCs will become mature plasma cells when returning to the lamina propria
through lymphatic vessels (Figure 3). The presence of antigens on DCs stimulated T cells
to initiate adaptive immunity [101,104].
The maternal microbiota are believed to be transferred to the mammary glands
by DCs through the above explained lymphatic system and the entero-mammary path-
way [105,106]. However, the precise selection of microbiota and how DCs differentiate
commensal or pathogenic bacteria are yet to be explored. Human gastrointestinal micro-
biota include a large and diverse community including hundreds of commensal bacteria
as well as pathogenic species. The pathogenic microflora induces specific inflammatory
responses against commensal microbiota in the competitive environment. Bloom et al.
demonstrated that germ-free mice injected with Gram-negative obligate anaerobes originat-
ing from the intestinal microbiota consortium would be sufficient to induce spontaneous
colitis [107]. The activation of inflammatory responses by the intestinal microflora could
mediate subsequent host pattern-recognition receptors [108]. This also leads to the re-
cruitment of specific macrophages and DCs to activate adaptive immune responses [107].
These mononuclear phagocytic cells (macrophages and DCs), which normally reside in the
intestinal lamina propria, also play a critical role in preventing inappropriate activation of
inflammatory responses to the normal microflora [107,108]. But how does the immune sys-
tem discriminate between commensal and pathogenic bacteria? Several commensal bacteria
including Bifidobacteria strains have been found to induce tolerance in monocyte-derived
DCs, which can recognize the specific pathogen-associated molecular patterns [99,108].
This step could help to precisely discriminate the intestinal microflora. This finding has
been utilized to explain DCs translocation of non-pathogenic gastrointestinal bacterial
strains like Lactobacillus and Bifidobacterium spp. [10].
We suggest that these translocation patterns could explain the entero-mammary
pathway transfer of gut microbiota into mammary glands (Figure 4). DCs sample the
commensal bacteria from maternal gut during pregnancy or after birth. After luminal
sampling, DCs could travel in the lymphatic systems and reach axial lymphatic nodes.
Then, DCs or microbes could migrate to the internal mammary lymphatic node [39,100,109].
Bioluminescence imaging was performed by de Andrés et al. to show that lactic acid
bacteria could be transported in vivo during pregnancy in mice [6]. In this study, two strains
of L. lactis MG1614 and L. salivarius PS2 were genetically modified to harbor luminescent
response producing lux operon genes. Both strains could be isolated, and the lux genes
were detected by PCR techniques from either milk or mammary gland biopsies after their
oral administration to pregnant mice [6]. This clearly proves the existence of an entero-link
between the gut and mammary glands involving lymphatic vessels and DCs (Figure 4).
We believe that the human lymphatic system is the major path for the translocation of
microorganisms in pregnant women. Perez et al. examined the presence of commensal
microflora in breast milk and peripheral blood [87]. The study reported that microbial
translocation occurred from the intestine to mesenteric lymph nodes and mammary glands
during end stages of pregnancy and lactation period in mice [87].
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4.3.3. Evidence on Gut Transmission to Breast Milk
Recently, several reports have shown that orally administrated probiotic microorgan-
isms to pregnant women could also be traced in the breast milk or in the infants’ stool
(Table 1). These studies have proven the homogeneity of bacterial strains with more precise
molecular techniques [48,110–112]. Abrahamsson et al. utilized culture-based techniques
and demonstrated that 12% of women in their probiotic group had viable L. reuteri strains
in their colostrum samples compared with 2% in the placebo group [111]. Simil rly, Ar-
royo et al. reported the presence of L. fermentum CECT5716 and L. salivarius CECT5713
in the milk of mothers who had undergone probiotic treatment for mastitis after 21 days
of supplementation [112]. In another small trial, four of 10 women had viable cultures
of L. rhamnosus strain LC705 isolated from breast milk samples after supplementation
with L. rhamnosus strain LC705 [113]. Additionally, the results of subsequent trials also
Appl. Sci. 2021, 11, 7247 14 of 25
suggested that maternal supplementation with L. fermentum CECT5716 may increase levels
of microbial population in the breast milk samples compared to the control and under
antibiotic treatments [48].
Table 1. Oral administration of probiotic strains and their respective re-detection methods.
References Oral Administration Method of Detection
Arroyo et al. [112] L. fermentum CECT5716 16s rRNA sequence
Nasiraii et al. [113] L. rhamnosus strain LC705 qPCR and 16S rRNA sequencing
Fernández et al. [52] L. salivarius PS2 MALDI-TOF and PFGE
Hurtado et al. [48] L. fermentum CECT5716 MALDI-TOF mass spectrometry
Jiménez et al. [27] L. salivarius CECT5713 and L. gasseri CECT5714 species-specific PCR, 16S rRNA sequencing and PFGE
The orally administrated bacterial strains detected in breast milk such as L. fermentum
CECT5716, L. salivarius CECT5713 [112], or L. rhamnosus strain LC705 [113] were initially
isolated from breast milk samples. This could imply the presence of selective sampling
and translocation of these bacteria, which have a natural affinity toward breast milk origin
bacteria. In this context, translocated bacteria might have specific induction mechanisms
to activate DCs [39]. Therefore, the natural gastrointestinal microorganisms or artificially
administered probiotic strains are selectively translocated from the maternal gut into
mammary glands through the entero-mammary pathway. Because of the small number of
mother–infant pairs studied, the biological validity of such results is limited.
GALT lymphoid cells migrate to the mammary gland in humans and rodents, estab-
lishing an entero-mammary bond and leading to the so-called “normal mucosal mecha-
nism,” in which immune cells migrate between distant mucosal sites. In contrast to these
observations, cattle studies have shown that lymphoid cell movement between the gut
and the mammary gland is limited, suggesting that the entero-mammary relationship in
ruminants is less functional [10]. While most mononuclear phagocytes in breast milk are
produced from peripheral blood monocytes, it has recently been hypothesized that a pro-
portion of these mononuclear phagocytes are dendritic cell-like cells that originate in GALT.
These cells collect luminal microbiota, and then transport these microbial components to
the mammary gland. This pathway teaches the neonatal immune system to recognize
commensal-associated bacterial molecular patterns and to react properly to them [19,83].
4.4. Final Microbial Consortia of Human Milk
Microbial population in the human milk could be originated from different sources.
Based on the core microbiota, it is suggested that the microbiota mainly originate from
the maternal digestive tract, breast areolar skin, and from the infants’ oral cavity during
suckling (Figure 5). The maternal gut bacteria seem to be selectively sampled and these
bacteria may reach the mammary glands through an endogenous route of the entero-
mammary pathway [10]. The gut origin lactic acid bacteria and others were sampled
by DCs and arrive to breast tissues and mesenteric lymphatic nodes. The lactic acid
bacteria probably form biofilms on the lactiferous tubules of the mammary duct system [91].
Using several developmental stages, the mammary gland trains for lactation [114]. In late
pregnancy, the alveolus system of the mammary gland will be maximally grown, and this
will provide a favorable environment for the formation of a biofilm. In addition, during
the suckling process, the microorganisms from the nipple and areola skin as well as the
infants’ oral cavity could be mixed in the breast milk produced [23]. However, in healthy
women, these common skin microflorae might not breach deep inside the alveolar system.
Biofilm formation by Staphylococcus or yeast are often related to the mastitis problem [15].
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5. Factors Affecting Microbial Load in the Breast Milk
5.1. Mode of Delivery
The method of delivery was one of the reasons that had a significant impact on
the microbiota composition of breast milk. There are two types of methods of delivery:
caesarean delivery and natural delivery. Caesarean is the delivery through the incisions
made in the mother’s abdomen and uterus. Toscano et al. [60] explained that the breast
milk produced by a mother who delivers naturally has a greater bacterial richness such as
commensal and p thogenic microorganisms (ex: Streptococcus and Haemophillus) compared
to C-section breast milk microbiota. Thus, C-section and natural delivery have higher
abundance of anaerobic bacteria compared to aerobic bacteria. As reported by Cabrera-
Rubio et al. [115], mothers who give birth via caesarean delivery have a low amount of
Leuconostocaceae and a high amount of Carnobacteriaceae compared with those who give
birth by natural delivery. Nevertheless, this finding contradicts the data from a study
published by Urbaniak et al. [116], which states that there is no effect on microbial profiles
through the mode of delivery.
Another study reported that the differences in the milk produced by both delivery
methods emerged from the oral colonization determined by the portal where the newborn
exits [116]. Specifically, infants born naturally acquire maternal bacteria from the vaginal
environment while maternal skin and breast milk transfer maternal bacteria to infants born
through the caesarean method [117]. In addition, work done by Khodayar-Pardo et al. [118]
r ported that the total concentration of Strep ococcus spp. was higher, and concentration
of Bifidobacterium spp. was lower in C-section delivery co pared to n tural delivery.
Meanwhile, natural delivery showed a higher correlation between Gammaproteobacteria and
Putrescine, but maintained a positive correlation with Pseudomonas fragi [11].
5.2. Lactation Period
Breast milk is an infant’s first intake of nutrition, and its structure varies from
colostrum to mature milk depending n the infant’s needs. Breast milk from healthy
mother is considered a continuous source of bacteria [3,115,118,119]. There are three stages
of lactation. Stage I involves secretory initiation, which appears during pregnancy and
regulates the development of secretory cells from mammary alveolar cells. At this stage,
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the mammary gland can produce the immunoglobulin-rich mammary secretion known as
colostrum. Next, in stage II, the onset of milk secretion, which is known by transition milk.
Lactose is the most common milk osmolyte, and an increase in intracellular lactose attracts
water into the lactocytes, resulting in a significant increase in milk volume in stage II of
lactogenesis. Finally, stage III is mature milk, which shows up one month after delivery
and is affected by hormonal signaling, lifestyle, and diet [115,118,119].
Boix-Amorós et al. [3] reported that all three stages of lactation are dominated by
Staphylococcus and Acinetobacter genera in colostrum, then, transition milk contained Pseu-
domonas and Streptococcus, and finally, Acinetobacter was abundant in mature milk. Besides,
their bacterial patterns were also composed of other genera including Finegoldia, Strepto-
coccus, Corynebacterium, and Peptoniphlus. The highest bacterial diversity was found in
the transition milk with nine genera of bacteria compared to colostrum and mature milk.
However, Staphylococcus aureus and epidermis were not detected in samples of healthy
mothers [3]. In contrast, in a study published by Li et al., no substantial alteration in the
abundance of 17 bacterial families among the samples that had been collected in the three
different stages of lactation was detected [36]. The common genera reported in colostrum
are Weisella, Leuconostoc, Staphylococcus, Streptococcus and Lactococcus, but the lactic acid
genera showed the highest abundance in milk between one and six months after giving
birth [115].
Khodayar-Pardo et al. reported that the total counts of Bifidobacterium and Enterococcus
increased throughout the lactation period [118]. Total concentration of Bifidobacterium spp.
and Enterococcus spp. were lower in colostrum compared to the transition and mature milk.
There was a good relationship between colostrum and transition milk as well as transition
milk and mature milk [118]. Bifidobacterium spp., Lactobacillus spp., and Staphylococcus
spp. showed positive correlation between colostrum and transitional milk. Moreover,
Lactobacillus is the most common genus in colostrum and the most abundant throughout
the lactation stage. Additionally, Bifidobacterium and Enterococcus counts were greater in
colostrum and showed differences in transitional milk and mature milk, which increased
throughout the lactation period and depends on the infants’ need in each period [10,120].
5.3. Maternal Nutrition
Breast milk is a complex biological fluid that contains many nutrients that come from
the maternal diet [1,49]. Offspring microbiome as well as maternal immunoglobulins and
macronutrients will be equally affected by the components of the breast milk [120]. The
energy content of breast milk and fat concentration will be affected by the nutritional status
of the mother. HBM not only contains diverse microbiota, but is also considered the greatest
source of nutrients for the infants’ stable growth and development [1,49]. Breast milk
proteins also show antimicrobial activities. One of the immunoglobulins known as SIgA
aids in fighting the pathogenic bacteria and yeast such as E. coli, V. cholerae, and C. albicans,
which can be found in human milk [51]. Breast-fed infants have fewer pathogenic bacteria
such as E. coli and Streptococci, but more Lactobacilli and Bifidobacterium whereas formula fed
infants had a higher number of enterococci and clostridia [45]. Antimicrobial components in
breast milk suppress the growth of potential pathogenic bacteria and activate the progress
of beneficial bacteria. Studies showed that antimicrobial compounds such as bacteriocins
and hydrogen peroxide from lactic acid bacteria can suppress the growth of various
pathogenic bacteria [37,45,51]. However, the difference in the physicochemical conditions
of the intestinal environment may favor some bacterial growth and suppress the others.
Probiotic, prebiotic, and symbiotic components in the body during prenatal and post-
natal periods trigger changes in maternal microbiota [45]. Generally, breast milk generates
an environment that aids the growth of Lactobacilli and Bifidobacterium and suppresses
pathogenic bacteria [18]. Both bacteria play an important role in reducing the risk of
spontaneous preterm delivery and in increasing the serum level erythrocyte glutathione
reductase (antioxidant activity) [121]. Besides, Lactobacillus GG (LGG) supplementations
raise the cord blood level. They also increase anti-inflammatory cytokines, IFNγ, and
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TGFb1 in HBM. The perinatal administration of LGG reduces the clinical effects of der-
matitis, itching frequency, plasma IgE levels, and elevated levels of IFNγ in skin biopsies.
The combination of LGG and B. lactis Bb12 ameliorates glucose homeostasis in healthy
young females during and after pregnancy. The findings from previous studies show that
probiotics supplements play a prominent role in preventing allergy development in both
the mother and infant [29,122,123].
Prebiotics such as oligosaccharides introduced into the small intestine of a mother for
digestion purposes are responsible for changing the maternal microbiota. O’Sullivan et al.
stated that the mass spectrometry-based tool revealed that HMOs support the competitive
growth of Bifidobacterium species such as Bifidobacterium longum and B. breve [28]. The
combination of prebiotics supplementation of galacto-oligosaccharide (GOS) and fructo-
oligosaccharide also changed the maternal microbiota. Moreover, the increase in bacterial
derived metabolites such as inulin and GOS increased the number of bacteria, which syn-
thesize folate. Folates are present in the large intestine for digestion and in blood stream for
fetal development. Short chain fatty acids (SCFAs) are another type of metabolite produced
by the prebiotics. SCFAs such as acetate, propionate, and butyrate are metabolized in
epithelial cells and serve as an energy supply for the mother as well as the developing
fetus. SCFAs also regulate the human gamma- to beta-globin gene switching process to
produce hemoglobin [1,121,124].
Symbiotic treatment combines probiotics and prebiotics that help combat allergic
disorders in children by altering the microbiome of the mother after delivery. They improve
the response to Haemophilus influenza type b (Hib) immunization, which increases antibody
concentrations responding to diphtheria, tetanus, or Hib. The presence of symbiotic
components inside a maternal body stimulates the growth of the delivered probiotic
bacteria. It further causes the formation of SCFAs that are anti-pathogenic and immune-
modulating agents. The changes occurring in the maternal microbiota by the existence
of probiotics, prebiotics, and symbiotic contribute to the offspring’s health during early
development [51,125].
5.4. Maternal Health Status
Maternal health is an important factor contributing to the microbial changes during
and after giving birth [126]. The changes in the levels of Bifidobacterium spp. and cytokines
correlate with obesity. The increase in Staphylococcus spp., leptin, and proinflammatory
fatty acid levels caused by obesity also reduces microbial diversity [127]. In the breast milk
of mothers with celiac disease, the levels of cytokines, Bacteroides spp., and Bifidobacterium
spp. were reduced [128]. Women diagnosed as HIV-positive had higher bacterial diversity
and higher prevalence of Lactobacillus spp. compared to HIV-negative women [129,130].
Obviously, women consume different types of medications, treatments, or antibiotics.
Antibiotics reduce the concentration of Bifidobacterium, Staphylococcus, and Eubacterium
spp. in milk samples while increasing the incidence of Lactobacillus, Bifidobacterium, and
Staphylococcus spp. [16]. Chemotherapy alters maternal microbiota by reducing bacterial
diversity as the chemo-drugs kill both beneficial and harmful cells and microorganisms in
the body [16,116].
5.5. Breast Feeding Practices
The World Health Organization (WHO) strongly recommends exclusive breastfeeding
at least for the first six months of life and a continuous breastfeeding for two years or
beyond is highly encouraged. However, some babies are unable to feed at the breast due to
abnormalities, prematurity, or other illnesses [131]. These babies are fed with expressed
milk or pumped milk. During recent years, expressed milk is common in many parts of the
world [132]. However, the impact of these indirect breastfeeding practices on the infant’s
health outcomes is still unknown. A recent study demonstrated that indirect breastfeeding
could cause a significant impact on microbial diversity and the composition of human
milk [133]. The study reported that the microbial composition of breast milk was differ-
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ent in indirect versus direct breastfeeding and also in manually expressed and pumped
milk samples. Higher abundance of opportunistic pathogens such as Stenotrophomonas
and Pseudomonas in the pumped milk could pose the risk of infants’ respiratory infection
asthma [133]. Another study conducted on 393 Canadian mother–infant pairs demon-
strated that pumped human milks were enriched with pathogenic microflora and had
a lower abundance of bifidobacterial compositions [134]. Both studies suggested that
direct contact of the infant’s mouth with maternal breast skin is important (Figure 5). The
co-occurrence of other microflora is associated with many variables including hygiene,
cleanliness of bottles and nipples, type of the pump, milk storage conditions, and duration
of storage [133,134]. However, pump-feeding is not recognized as a cause of infant diseases
and other health complications. Pump feeding must be acknowledged as this method
is the only savior for some mothers, especially those suffering from mastitis. However,
pump feeding of breast milk is not similar to direct breast feeding. More studies must
be conducted to understand the impact of pumping on milk composition to optimize
the process.
6. Functionality of Human Milk Microbiota
Because breast milk contains a variety of commensal bacteria, it is considered as
a reservoir of bioactive ingredients useful for infants. The microbiota of breast milk
contributes to infant wellbeing for its ability to prevent infections, inflammations, allergies,
and Enterocolitis.
6.1. Anti-Infections
Weisella, Leuconostoc, Staphylococcus, Streptococcus, and Lactococcus are important or-
ganisms in colostrum samples. During newborn development, approximately from one to
six months, the inhabitants of the oral cavity such as Veillonella, Leptotrichia, and Prevotella
increased significantly in the breast milk [115]. These microorganisms also inhibited the
growth of E. coli, Salmonella spp., and Listeria monocytogenes [4]. Next, reuterin secreted by
L. reuteri is another antimicrobial compound for the colonization of infant gut. L. gasseri
CECT5714, L. salivarius CECT5713 and L. fermentum CECT5714 have the capability to inhibit
the adhesion of Salmonella cholerasuis to mucins [4,42]. Besides, the growth of pathogen mi-
croorganisms such as S. aureus, S. typhimurium, Yersinia enterocolitica, and C. perfringens are
controlled by Lactobacilli and Bifidobacteria. The Klebsiella cloacae group have been reported
to be frequent gastrointestinal colonizers of neonates [33].
6.2. Anti-Inflammation
The microbiota of human milk reduces the inflammatory process, which involves the
response of TH2 lymphocytes. L. fermentum CECT5716 and L. salivarius CECT5713 activate
the NK cells, activate the CD4and CD8 T cells, and regulatory T cells. Vaccination against
diseases such as poliomyelitis, tetanus, and diphtheria improved the immunomodulatory
effects of breast milk microbiota in humoral response in breast-fed babies more than
formula-fed infants [4,135].
6.3. Metabolic Functions
Microbiota of human milk produces different types of metabolites. Lactate-utilizing
bacteria in the human milk, namely Eubacterium and Anaerostipes species produce butyrate.
Butyrate, being a functional metabolite that plays a crucial role in modulating intestinal
function of infant by increasing fecal concentration, fecal moisture, volume, and stool
frequency. Other functions of butyrate in early age development include gene expression,
cell differentiation, gut tissue development, immune modulation, oxidative stress reduction,
and diarrhea control [83,125].
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6.4. Allergic Prevention
The intestinal microbiota of a breast-fed infant is predominated by Bifidobacterium.
Data showed a significant correlation in Bifidobacterium adolescentis and Bifidobacterium
bifidum frequencies and counts in women suffering from allergies [136]. Besides, the
amount of Bifidobacterium is lower in allergic mothers when compared to non-allergic
mothers. Accordingly, the feces of infants from allergic mothers contain lower amount of
Bifidobacterium. Thus, Bifidobacterium in breast milk contributes to allergic prevention in
the mother and newborn [136]. Chiu et al. performed an experiment of different strains
of Bifidobacterium to determine the potential immunomodulatory strains that can cause
human peripheral blood monocular cells to produce cytokines [137]. Data showed that
B. adolescentis DB-2458, B. longum subsp. infantis GB-1496, and B. longum HB-762 were the
most potential species to induce a high level of IL-10 and TGF-b cytokines.
6.5. Enterocolitis Prevention
Some of the bacteria present in breast milk can increase mucin development and
decrease intestinal permeability to improve the function of the intestinal barrier [115]. The
maternal immune system consists of both secreted and diffused immunoglobulins such as
SIgA and IgG. The breast milk contains IgG, SIgA, the most important bacterial pathogen of
the neonate, E. coli, specific growth-enhancing lactobacilli, macrophages, and lymphocytes,
which prevent the development of enterocolitis in infants [138,139].
6.6. Growth and Development of Immune System
The human gut microbiota, which consists of 500 to 1000 microbial species, is also
responsible for the enhancement of infant immune system. Most of the fecal population is
composed of Bifidobacteria, with smaller numbers of E. coli, Bacteroides, and Clostridia [140].
Infants undergoing caesarean delivery have lower numbers of Bifidobacteria and Bacteroides,
whereas they are more often colonized with C. difficile. These infants have higher chances
of developing atopic disease and prematurity. Many oligosaccharides and glycoconjugates
produced by glycosyltransferases in the mammary gland are transferred to human milk
and serve as receptors to interfere with the binding of pathogens to epithelial cells. This
prevention is necessary to enhance the newborn’s immune system through the breast
milk [45,141].
7. Conclusions
The human milk consists of a dynamic microbial ecology with extraordinary properties
and functions. These microorganisms are actively transferred from mother to infant via
breast-feeding. The human milk microbiota have been proven to have great impact on the
neonatal immune system, optimizing nutrient metabolism, the intestinal barrier function,
and enhancing maturation of the digestive tract. These microorganisms enter human
milk via several pathways including spreading through the mother’s breast skin and
movement from the infant’s oral cavity and through a special route by the entero-mammary
pathway. DCs offer unique microbial translocation mechanisms from the maternal gut into
mammary glands. Among the trillions of strains, maternal gut commensal microorganisms
are specifically selected and translocated. Several fundamental questions regarding the
gut and breast mammary gland axis remain unanswered. The gut–mammary gland axis
has a paramount role in the human body system and programming health for life. A
precise understanding of the existence of the entero-mammary pathway requires more
sophisticated experimental and clinical studies. The growing technology of -omic tools such
as metagenomics, transcriptomics, and metabolomics has opened new avenues to identify
and understand the existence of specific bacteria in the human milk and the gut. The strain-
level identification of microbiome must also be performed in the bloodstream and within
the immune cells involved in the entero-mammary transfer. In conclusion, a comprehensive
understanding of the complete scenario of events of such mechanistic pathways will offer
novel interventions to improve the health status of newborns. Emerging knowledge offers
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novel opportunities to modulate the gut microbial composition to promote maternal-
infant health.
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78. Wilczyńska, P.; Skarżyńska, E.; Lisowska-Myjak, B. Meconium microbiome as a new source of information about long-term health
and disease: Questions and answers. J. Matern. Fetal Neonatal Med. 2019, 32, 681–686. [CrossRef]
79. Korpela, K.; Costea, P.I.; Coelho, L.P.; Kandels-Lewis, S.; Willemsen, G.; Boomsma, D.I.; Segata, N.; Bork, P. Selective maternal
seeding and environment shape the human gut microbiome. Genome Res. 2018, 28, 561–568. [CrossRef]
80. Schmidt, T.; Raes, J.; Bork, P. The human gut microbiome: From association to modulation. Cell 2018, 172, 1198–1215. [CrossRef]
81. Gohir, W.; Whelan, F.J.; Surette, M.G.; Moore, C.; Schertzer, J.D.; Sloboda, D.M. Pregnancy-related changes in the maternal gut
microbiota are dependent upon the mother’s periconceptional diet. Gut Microbes 2015, 6, 310–320. [CrossRef]
82. Barko, P.; McMichael, M.; Swanson, K.; Williams, D. The gastrointestinal microbiome: A Review. J. Vet. Intern. Med. 2017, 32, 9–25.
[CrossRef] [PubMed]
83. Koren, O.; Goodrich, J.K.; Cullender, T.C.; Spor, A.; Laitinen, K.; Bäckhed, H.K.; Gonzalez, A.; Werner, J.J.; Angenent, L.T.; Knight,
R.; et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012, 150, 470–480. [CrossRef]
84. Martín, R.; Langella, P. Emerging health concepts in the probiotics field: Streamlining the definitions. Front. Microbiol. 2019, 10,
1047. [CrossRef] [PubMed]
85. Albesharat, R.; Ehrmann, M.A.; Korakli, M.; Yazaji, S.; Vogel, R.F. Phenotypic and genotypic analyses of lactic acid bacteria in
local fermented food, breast milk and faeces of mothers and their babies. Syst. Appl. Microbiol. 2011, 34, 148–155. [CrossRef]
[PubMed]
86. Milani, C.; Mancabelli, L.; Lugli, G.A.; Duranti, S.; Turroni, F.; Ferrario, C.; Mangifesta, M.; Viappiani, A.; Ferretti, P.; Gorfer,
V.; et al. Exploring vertical transmission of bifidobacteria from mother to child. Appl. Environ. Microbiol. 2015, 81, 7078–7087.
[CrossRef]
87. Perez, P.F.; Doré, J.; Leclerc, M.; Levenez, F.; Benyacoub, J.; Serrant, P.; Segura-Roggero, I.; Schiffrin, E.J.; Donnet-Hughes, A.
bacterial imprinting of the neonatal immune system: Lessons from maternal cells? Pediatrics 2007, 119, e724–e732. [CrossRef]
88. Palmeira, P.; Quinello, C.; Silveira-Lessa, A.L.; Zago, C.A.; Carneiro-Sampaio, M. IgG placental transfer in healthy and pathological
pregnancies. Clin. Dev. Immunol. 2011, 2012, 1–13. [CrossRef]
89. Nagendran, V.; Emmanuel, N.; Bansal, A.S. Does the maternal serum IgG level during pregnancy in primary antibody deficiency
influence the IgG level in the newborn? Case Rep. Immunol. 2015, 2015, 1–4. [CrossRef]
90. Brandtzaeg, P. Mucosal immunity: Integration between mother and the breast-fed infant. Vaccine 2003, 21, 3382–3388. [CrossRef]
91. Brandtzaeg, P. The mucosal immune system and its integration with the mammary glands. J. Pediatr. 2010, 156, S8–S15. [CrossRef]
92. Rodríguez, J.; Fernández, L.; Verhasselt, V. The gut-breast axis: Programming health for life. Nutrients 2021, 13, 606. [CrossRef]
[PubMed]
93. Wilson, E.; Butcher, E.C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and
IgA antibody transfer to the neonate. J. Exp. Med. 2004, 200, 805–809. [CrossRef]
94. Rahman, M.; Mohammed, S. Breast cancer metastasis and the lymphatic system. Oncol. Lett. 2015, 10, 1233–1239. [CrossRef]
95. Suami, H.; Pan, W.-R.; Taylor, G.I. Historical review of breast lymphatic studies. Clin. Anat. 2009, 22, 531–536. [CrossRef]
96. Adlerberth, I.; Wold, A.E. Establishment of the gut microbiota in Western infants. Acta Paediatr. Int. J. Paediatr. 2009, 98, 229–238.
[CrossRef] [PubMed]
97. Gutzeit, C.; Magri, G.; Cerutti, A. Intestinal IgA production and its role in host-microbe interaction. Immunol. Rev. 2014, 260,
76–85. [CrossRef] [PubMed]
Appl. Sci. 2021, 11, 7247 24 of 25
98. Worbs, T.; Hammerschmidt, S.I.; Förster, R. Dendritic cell migration in health and disease. Nat. Rev. Immunol. 2016, 17, 30–48.
[CrossRef]
99. Aliberti, J. Immunity and tolerance induced by intestinal mucosal dendritic cells. Mediat. Inflamm. 2016, 2016, 1–8. [CrossRef]
100. Martín-Fontecha, A.; Lanzavecchia, A.; Sallusto, F. Dendritic cell migration to peripheral lymph nodes. Organotypic Models Drug
Dev. 2008, 188, 31–49. [CrossRef]
101. Farache, J.; Koren, I.; Milo, I.; Gurevich, I.; Kim, K.-W.; Zigmond, E.; Furtado, G.C.; Lira, S.A.; Shakhar, G. Luminal bacteria recruit
CD103+ dendritic cells into the intestinal epithelium to sample bacterial antigens for presentation. Immunity 2013, 38, 581–595.
[CrossRef] [PubMed]
102. Griffin, A.J.; McSorley, S.J. Development of protective immunity to Salmonella, a mucosal pathogen with a systemic agenda.
Mucosal Immunol. 2011, 4, 371–382. [CrossRef] [PubMed]
103. Knoop, K.; Newberry, R.D. Goblet cells: Multifaceted players in immunity at mucosal surfaces. Mucosal Immunol. 2018, 11,
1551–1557. [CrossRef]
104. Bekiaris, V.; Persson, E.K.; Agace, W.W. Intestinal dendritic cells in the regulation of mucosal immunity. Immunol. Rev. 2014, 260,
86–101. [CrossRef] [PubMed]
105. Kordy, K.; Gaufin, T.; Mwangi, M.; Li, F.; Cerini, C.; Lee, D.J.; Adisetiyo, H.; Woodward, C.; Pannaraj, P.S.; Tobin, N.H.; et al.
Contributions to human breast milk microbiome and enteromammary transfer of Bifidobacterium breve. PLoS ONE 2020, 15,
e0219633. [CrossRef]
106. Rescigno, M.; Urbano, M.; Valzasina, B.; Francolini, M.; Rotta, G.; Bonasio, R.; Granucci, F.; Kraehenbuhl, J.-P.; Ricciardi-Castagnoli,
P. Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria. Nat. Immunol. 2001,
2, 361–367. [CrossRef] [PubMed]
107. Bloom, S.; Bijanki, V.; Nava, G.; Sun, L.; Malvin, N.P.; Donermeyer, D.L.; Dunne, W.M.; Allen, P.M.; Stappenbeck, T.S. Commensal
bacteroides species induce colitis in host-genotype-specific fashion in a mouse model of inflammatory bowel disease. Cell Host
Microbe 2011, 9, 390–403. [CrossRef]
108. Franchi, L.; Kamada, N.; Nakamura, Y.; Burberry, A.; Kuffa, P.; Suzuki, S.; Shaw, M.H.; Kim, Y.-G.; Núñez, G. NLRC4-driven
production of IL-1β discriminates between pathogenic and commensal bacteria and promotes host intestinal defense. Nat.
Immunol. 2012, 13, 449–456. [CrossRef]
109. Wendland, M.; Willenzon, S.; Kocks, J.; Davalos-Misslitz, A.C.; Hammerschmidt, S.I.; Schumann, K.; Kremmer, E.; Sixt, M.;
Hoffmeyer, A.; Pabst, O.; et al. Lymph node T cell homeostasis relies on steady state homing of dendritic cells. Immunity 2011, 35,
945–957. [CrossRef]
110. Elias, J.; Bozzo, P.; Einarson, A. Are probiotics safe for use during pregnancy and lactation? Canadian family physician. Can. Fam.
Physician 2011, 57, 299–301.
111. Abrahamsson, T.R.; Sinkiewicz, G.; Jakobsson, T.; Fredrikson, M.; Björkstén, B. Probiotic Lactobacilli in breast milk and infant stool
in relation to oral intake during the first year of life. J. Pediatr. Gastroenterol. Nutr. 2009, 49, 349–354. [CrossRef]
112. Arroyo, R.; Martin, V.; Maldonado, A.; Jiménez, E.; Fernández, L.; Rodríguez, J. Treatment of Infectious mastitis during lactation:
Antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin. Infect. Dis. 2010, 50, 1551–1558. [CrossRef]
113. Nasiraii, L.R. Investigation of lactobacilli from mother’s breast milk who were placed on probiotic diet. Afr. J. Microbiol. Res. 2011,
5, 1581–1585. [CrossRef]
114. Macias, H.; Hinck, L. Mammary gland development. Wiley Interdiscip. Rev. Dev. Biol. 2012, 1, 533–557. [CrossRef] [PubMed]
115. Cabrera-Rubio, R.; Collado, M.C.; Laitinen, K.; Salminen, S.; Isolauri, E.; Miras, A.D.; Jackson, R.N.; Jackson, S.N.; Goldstone, A.P.;
Olbers, T.; et al. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am.
J. Clin. Nutr. 2012, 96, 544–551. [CrossRef]
116. Urbaniak, C.; Angelini, M.; Gloor, G.B.; Reid, G. Human milk microbiota profiles in relation to birthing method, gestation and
infant gender. Microbiome 2016, 4, 1–9. [CrossRef]
117. Hoashi, M.; Meche, L.; Mahal, L.; Bakacs, E.; Nardella, D.; Naftolin, F.; Bar-Yam, N.; Dominguez-Bello, M.G. Human milk bacterial
and glycosylation patterns differ by delivery mode. Reprod. Sci. 2015, 23, 902–907. [CrossRef]
118. Khodayarpardo, P.; Pascual, L.M.; Collado, M.C.; Martinez-Costa, C. Impact of lactation stage, gestational age and mode of
delivery on breast milk microbiota. J. Perinatol. 2014, 34, 599–605. [CrossRef] [PubMed]
119. Nommsen-Rivers, L.A.; Chantry, C.J.; Peerson, J.M.; Cohen, R.J.; Dewey, K.G.; Appleton, K.M.; Rogers, P.J.; Ness, A.R. Delayed
onset of lactogenesis among first-time mothers is related to maternal obesity and factors associated with ineffective breastfeeding.
Am. J. Clin. Nutr. 2010, 92, 574–584. [CrossRef]
120. Chu, D.M.; Meyer, K.M.; Prince, A.L.; Aagaard, K.M. Impact of maternal nutrition in pregnancy and lactation on offspring gut
microbial composition and function. Gut Microbes 2016, 7, 459–470. [CrossRef]
121. Prescott, S.L.; Wickens, K.; Westcott, L.; Jung, W.; Currie, H.; Black, P.N.; Stanley, T.V.; Mitchell, E.A.; Fitzharris, P.; Siebers, R.; et al.
Supplementation with Lactobacillus rhamnosus or Bifidobacterium lactis probiotics in pregnancy increases cord blood interferon-γ
and breast milk transforming growth factor-β and immunoglobin A detection. Clin. Exp. Allergy 2008, 38, 1606–1614. [CrossRef]
[PubMed]
122. Licciardi, P.V.; Ismail, I.H.; Balloch, A.; Mui, M.; Hoe, E.; Lamb, K.; Tang, M.L.K. Maternal supplementation with LGG reduces
vaccine-specific immune responses in infants at high-risk of developing allergic disease. Front. Immunol. 2013, 4, 381. [CrossRef]
[PubMed]
Appl. Sci. 2021, 11, 7247 25 of 25
123. Boyle, R.J.; Ismail, I.H.; Kivivuori, S.; Licciardi, P.V.; Robins-Browne, R.M.; Mah, L.-J.; Axelrad, C.; Moore, S.; Donath, S.; Carlin,
J.B.; et al. Lactobacillus GG treatment during pregnancy for the prevention of eczema: A randomized controlled trial. Allergy
2010, 66, 509–516. [CrossRef]
124. Liakopoulou, E.; Blau, C.A.; Li, Q.; Josephson, B.; Wolf, J.A.; Fournarakis, B.; Raisys, V.; Dover, G.; Papayannopoulou, T.;
Stamatoyannopoulos, G. Stimulation of fetal hemoglobin production by short chain fatty acids. Blood 1995, 85, 3227–3235.
[CrossRef]
125. Wopereis, H.; Sim, K.; Shaw, A.; Warner, J.O.; Knol, J.; Kroll, J.S. Intestinal microbiota in infants at high risk for allergy: Effects of
prebiotics and role in eczema development. J. Allergy Clin. Immunol. 2018, 141, 1334–1342.e5. [CrossRef]
126. Le Doare, K.; Holder, B.; Bassett, A.; Pannaraj, P.S. Mother’s milk: A purposeful contribution to the development of the infant
microbiota and immunity. Front. Immunol. 2018, 9, 361. [CrossRef]
127. Kumar, H.; du Toit, E.; Kulkarni, A.; Aakko, J.; Linderborg, K.M.; Zhang, Y.; Nicol, M.; Isolauri, E.; Yang, B.; Collado, M.C.; et al.
Distinct patterns in human milk microbiota and fatty acid profiles across specific geographic locations. Front. Microbiol. 2016, 7,
1619. [CrossRef] [PubMed]
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